michigan semaglutide nausea lawsuit Tirzepatide Deaths Some podiatrists are voicing concerns

Greater weight loss potential The SURMOUNT-5 trial, published in NEJM in 2025, directly compared tirzepatide against semaglutide in adults with obesity (without diabetes)

If you exercise, live in hot weather, or take semaglutide or other GLP-1 medications like Ozempic or Wegovy, add more to that baseline

The primary endpoints were MASH resolution with no worsening of fibrosis and improvement of fibrosis with no worsening of MASH

Semaglutide The health benefits Semaglutide provides to overweight and obese patients are: Blood sugar-lowering effects without any increase in hypoglycemia

If you want semaglutide for weight management, Wegovy is the licensed option